A Study Of Advanced Magnetic Resonance Imaging For Detection And Characterization Of Prostate Cancer

Overview

About this study

The purpose of this study is to evaluate and validate our novel 3D DWI for detection and characterization of prostate cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis/disease status: Patients being evaluated for prostate cancer. For healthy volunteers, no specific disease status.

  •  Age ≥ 18 years. To note, the patients enrolled in the study will be towards older age group since patients with prostate cancer and with pelvic metal implants are generally towards middle age to elderly population. The age distribution will be between 18 years and up to 80 years of age, without any additional age-related restrictions. 

  • Performance status: ECOG Status 0, 1 and 2.

  • This project is focused on prostate imaging. As such, all subjects enrolled in this project will be men. No women will be included in this study.

  • Patients with or without proven MRI compatible pelvic metal implants

  • Ability to understand and the willingness to sign a written informed consent.

Exclusion Criteria:

  • Any contraindication to MRI per Radiology Department’s routine protocol, e.g., MRI-incompatible objects, including but not limited to medical devices (e.g., pacemakers, AICD, etc.) and other foreign bodies.

  • Patients with uncontrollable claustrophobia, severe lower back pain, and uncontrollable tremors, to the point that it would render them unable to tolerate an MRI study.

  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the investigator, would limit compliance with study requirements.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 01/28/2026. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Ananth Madhuranthakam, Ph.D.

Contact us for the latest status

Contact information:

Ryan Jacobson

5075388024

jacobson.ryan1@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20599103

Mayo Clinic Footer